• Home
  1. Home
  2. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
Scientific article
English

Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients

ContributorsVallin, Mélanie; Guillaud, Olivier; Morard, Isabelle; Gagnieu, Marie-Claude; Mentha, Gilles; Adham, Mustapha; Morelon, Emmanuel; Boillot, Olivier; Giostra, Emiliano; Dumortier, Jérôme
Published inClinical transplantation, vol. 25, no. 4, p. 660-669
Publication date2011
Abstract

The aim of this study was to evaluate the tolerability of the conversion from calcineurin inhibitor (CNI) to everolimus (ERL) in maintenance liver transplant (LT) recipients.

Keywords
  • Calcineurin/antagonists & inhibitors
  • Cohort Studies
  • Cyclosporine/therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection/drug therapy
  • Graft Survival
  • Humans
  • Immune Tolerance/drug effects
  • Immunosuppressive Agents/therapeutic use
  • Liver Transplantation
  • Male
  • Middle Aged
  • Sirolimus/analogs & derivatives/therapeutic use
  • Survival Rate
  • Tacrolimus/therapeutic use
  • Treatment Outcome
Affiliation entities
Research groups
Citation (ISO format)
VALLIN, Mélanie et al. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. In: Clinical transplantation, 2011, vol. 25, n° 4, p. 660–669. doi: 10.1111/j.1399-0012.2010.01370.x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0902-0063
601views
0downloads

Technical informations

Creation17/12/2012 15:54:00
First validation17/12/2012 15:54:00
Update14/03/2023 19:55:05
Status update14/03/2023 19:55:05
Last indexation30/10/2024 08:19:24
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack